Latest News about Expert Ideas
Recent news which mentions Expert Ideas
After Trump's Win, It's Time To Take Profits On Gold
November 11, 2024
From Benzinga
Top 4 Real Estate Stocks That May Rocket Higher In November
November 11, 2024
From Benzinga
Bitcoin Blasts Past $82,000: 'Buy Everything You Can,' Says Bernstein
November 11, 2024
From Benzinga
ARS Pharmaceuticals Inks Licensing Pact For Neffy Allergic Reaction Treatment, Analyst Sees Further Stock Upside Despite 200% Surge In 2024
November 11, 2024
From Benzinga
Top 4 Health Care Stocks That May Plunge This Quarter
November 11, 2024
From Benzinga
US Stocks Likely To Open Higher After Registering Best Week Of Year Following Trump Win: Markets Still Have Juice Left As Investors Eye CPI Data, Says Expert
November 11, 2024
From Benzinga
Cathie Wood Predicts Trump's White House Return Will Ignite Reagan-Era Economic Boom Through Deregulation And Tax Cuts: 'Likely To Turbocharge The US Economy'
November 11, 2024
From Benzinga
Donald Trump's Second Term Could Reshape US Healthcare System, With Major Impacts on Affordable Care Act And Medicare
November 09, 2024
From Benzinga
BioNTech Earns Upgrade From Goldman Sachs As Investment Thesis Shifts Toward Cancer Potential
November 09, 2024
From Benzinga
Tradepulse Power Inflow Alert: Costco Wholesale Corp. Receives Alert And Rises Over 4%
November 09, 2024
Tickers
COST
From Benzinga
Trump Presidency Could Be A Boon For Small Cap Stocks: Fundstrat's Tom Lee Sees Them Doubling Over Next 2 Years
November 09, 2024
Tickers
NEWS
From Benzinga
From Benzinga
EXCLUSIVE: Trump Victory Triggers 'Reshoring' Rally As Supply Chain Security Outweighs Cost
November 08, 2024
From Benzinga
SolarEdge Is A 'Show-Me Story' After Disappointing Q3: Analyst
November 08, 2024
From Benzinga
Bitcoin, Ethereum, Dogecoin Close The Week Trading Sideways
November 08, 2024
From Benzinga
Stock Of The Day: Expedia Appears Overbought And May Reverse
November 08, 2024
Tickers
EXPE
From Benzinga
Bristol-Myers Squibb Leads Biopharma Recovery With Almost 25% Growth In Market Cap, But Novo Nordisk And Lilly Suffer Market Setbacks
November 08, 2024
From Benzinga
Bath & Body Works Stock Downgraded Due To This Risk: Details
November 08, 2024
From Benzinga
Moderna's Q3 Earnings Beat Overshadowed By Vaccine Demand Slowdown And Market Share Concerns, Analysts Warn
November 08, 2024
From Benzinga
Pyxis Oncology's Cancer Drug Platform Shows Potential, Analyst Sees Over 190% Upside
November 08, 2024
From Benzinga
Lucid's Delivery Gains, New SUV Can't Shake Profit Concerns
November 08, 2024
From Benzinga
ADC Therapeutics Faces Competitive Oncology Market But Analyst Sees 100% Upside - Here's Why
November 08, 2024
From Benzinga
Fragrance Maker IFF Positioned For Growth With Revitalized R&D And Attractive Valuation: Analyst
November 08, 2024
From Benzinga
Wingstop's Strong Unit Economics - Goldman Sachs Upgrades Stock
November 08, 2024
From Benzinga
Penn Entertainment Analysts Say 'All Eyes Remain On ESPN Bet' After Q3 Earnings Miss
November 08, 2024
From Benzinga
Upstart's Enhanced Lending Model Drives Revenue Growth, Analyst Sees Further Upside Potential
November 08, 2024
From Benzinga
Bitcoin To $200,000, Ethereum To $10,000 And Crypto Market Cap To 4X By End Of 2025, Says Standard Chartered
November 08, 2024
From Benzinga
EPAM Inks Strategic Deals, Enjoys Robust Tax Benefits: Analyst
November 08, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.